Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

In vitro fine particle dose of drug formulation used in asthma & COPD

Lois Slator, Dirk Von Hollen, Lucy E. A. Hardaker
European Respiratory Journal 2020 56: 3185; DOI: 10.1183/13993003.congress-2020.3185
Lois Slator
1Respironics Respiratory Drug Delivery (UK) Ltd, a business of Philips Electronics UK Limited, Chichester (West Sussex), United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lois.slator@philips.com
Dirk Von Hollen
2Respironics Inc., a Philips Healthcare company, Murraysville, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucy E. A. Hardaker
1Respironics Respiratory Drug Delivery (UK) Ltd, a business of Philips Electronics UK Limited, Chichester (West Sussex), United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 56 no. suppl 64
DOI 
https://doi.org/10.1183/13993003.congress-2020.3185

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online October 28, 2020.

Copyright & Usage 
Copyright ©the authors 2020

Author Information

  1. Lois Slator1⇑,
  2. Dirk Von Hollen2 and
  3. Lucy E. A. Hardaker1
  1. 1Respironics Respiratory Drug Delivery (UK) Ltd, a business of Philips Electronics UK Limited, Chichester (West Sussex), United Kingdom
  2. 2Respironics Inc., a Philips Healthcare company, Murraysville, United States of America
  1. Lois Slator, Respironics Respiratory Drug Delivery (UK) Ltd, a business of Philips Electronics UK Limited, Chichester (West Sussex), United Kingdom. E-mail: lois.slator{at}philips.com

Article usage

Article usage: October 2020 to May 2023

AbstractFullPdf
Oct 2020500
Nov 20204900
Dec 20208700
Jan 20211900
Feb 20211400
Mar 2021700
Apr 2021800
May 20212800
Jun 20211100
Jul 20211100
Aug 20212200
Sep 20212500
Oct 20211400
Nov 20211800
Dec 20211100
Jan 20222200
Feb 20221800
Mar 2022300
Apr 20221100
May 2022900
Jun 2022900
Jul 20221700
Aug 20221000
Sep 2022700
Oct 2022300
Nov 20221000
Dec 2022400
Jan 2023700
Feb 2023900
Mar 20231300
Apr 2023600
May 2023200

Altmetrics

Previous
Back to top
Vol 56 Issue suppl 64 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In vitro fine particle dose of drug formulation used in asthma & COPD
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
In vitro fine particle dose of drug formulation used in asthma & COPD
Lois Slator, Dirk Von Hollen, Lucy E. A. Hardaker
European Respiratory Journal Sep 2020, 56 (suppl 64) 3185; DOI: 10.1183/13993003.congress-2020.3185

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
In vitro fine particle dose of drug formulation used in asthma & COPD
Lois Slator, Dirk Von Hollen, Lucy E. A. Hardaker
European Respiratory Journal Sep 2020, 56 (suppl 64) 3185; DOI: 10.1183/13993003.congress-2020.3185
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Impact of biologic therapy in severe asthma with nasal polyps
  • Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma
  • Real-life impact of weight in severe eosinophilic asthma patients treated with benralizumab
Show more Airway pharmacology and treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society